Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

João Paulo Maia-de-Oliveira

Biographic Data

ID9655899
NAMEJoão Paulo Maia-de-Oliveira
GIVEN NAMESJoão Paulo
FAMILY NAMEMaia-de-Oliveira
SIGNATUREMAIA-DE-OLIVEIRA J P
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2016
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Psychophysiological responses to group cognitive-behavioral therapy in depressive patients

    Open Access•Yves Martins Varela, Raíssa Nóbrega de Almeida et al.•ARTICLE•Current Psychology•2023

  • Moderators of ayahuasca’s biological antidepressant action

    Open Access•Geovan Menezes de Sousa, Vagner Deuel De O Tavares et al.•ARTICLE•Frontiers in Psychiatry•2022

    In summary, some specific emotional and physiological parameters during experimental ayahuasca session were revealed as critical moderators of the improvement of major depression biomarkers, mainly BDNF and SC two days after ayahuasca intake. These findings contribute to paving the way for future studies investigating the biological antidepressant response to psychedelic therapy

  • Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

    Rafael Faria Sanches, Flávia de Lima Osório et al.•ARTICLE•Journal of Clinical Psychopharmacol…•2016

    Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine, a 5-HT2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group recently reported that ayahuasca administration was associated with fast-acting antidepressive effects in 6 depressive patients. The objective of the present work was to assess the antidepressive potentials of ayahuasca in a bigger sample and to investigate its effects on reg…

No prominent works on this page.

  • Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

    Rafael Faria Sanches, Flávia de Lima Osório et al.•ARTICLE•Journal of Clinical Psychopharmacol…•2016

    Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine, a 5-HT2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group recently reported that ayahuasca administration was associated with fast-acting antidepressive effects in 6 depressive patients. The objective of the present work was to assess the antidepressive potentials of ayahuasca in a bigger sample and to investigate its effects on reg…

  • Moderators of ayahuasca’s biological antidepressant action

    Open Access•Geovan Menezes de Sousa, Vagner Deuel De O Tavares et al.•ARTICLE•Frontiers in Psychiatry•2022

    In summary, some specific emotional and physiological parameters during experimental ayahuasca session were revealed as critical moderators of the improvement of major depression biomarkers, mainly BDNF and SC two days after ayahuasca intake. These findings contribute to paving the way for future studies investigating the biological antidepressant response to psychedelic therapy

  • Psychophysiological responses to group cognitive-behavioral therapy in depressive patients

    Open Access•Yves Martins Varela, Raíssa Nóbrega de Almeida et al.•ARTICLE•Current Psychology•2023

Medicine (3 works) · Psychiatry (3 works) · Psychology (3 works) · Anxiety (2 works) · Ayahuasca (2 works) · Biochemical Analysis and Sensing Techniques (2 works) · Major depressive disorder (2 works) · Psychedelics and Drug Studies (2 works) · Action (physics (1 works) · Anesthesia (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae